收藏切换
Effects of febuxostat combined with hemodialysis on chronic kidney disease and effect on fibroblast growth factor 23 and bone metabolism
收藏切换
Jing ZHANG1, Xiaoning YANG1, Lina LI2, Xiaomi PAN2, *
World Clinical Drug | 2023, 44(6) : 632 - 637
Less
收藏切换
World Clinical Drug | 2023, 44(6): 632-637
• Article •
Effects of febuxostat combined with hemodialysis on chronic kidney disease and effect on fibroblast growth factor 23 and bone metabolism
Full
Jing ZHANG1, Xiaoning YANG1, Lina LI2, Xiaomi PAN2, *
Affiliations
  • 1.Department of Internal Medicine, Qingdao Municipal Hospital Group, Qingdao Geriatric Hospital, Qingdao 266071, Shandong Province, China
  • 2.Blood Purification Center, Qingdao Municipal Hospital Group, Qingdao Geriatric Hospital, Qingdao 266071, Shandong Province, China
Published: 2023-06-10 doi: 10.13683/j.wph.2023.06.020
Outline
收藏切换
Objective

To investigate the effect of febuxostat combined with hemodialysis in the treatment of chronic kidney disease (CKD) and its effect on fibroblast growth factor (FGF) 23 and bone metabolism.

Methods

A total of 105 patients with CKD who treated at the department of nephrology in our hospital from February 2020 to February 2021 were selected and divided into experimental group (n=53, hemodialysis+febuxostat) and control group (n=52, hemodialysis) by random number table method. The clinical efficacy, serum FGF23, serum uric acid, serum calcium, blood phosphorus, parathyroid hormone (PTH), serum creatinine (Scr), blood urea nitrogen (BUN) and occurrence of adverse reactions were compared between the two groups.

Results

After treatment, there was a statistically significant difference in the total effective rate between the control group and the experimental group (51.92% vs 81.13%, P<0.05), but no statistically significant difference in the incidence of adverse reactions (9.43% vs 19.23%, P>0.05). The levels of serum FGF23, blood uric acid, blood phosphorus, PTH, Scr and BUN in both groups were decreased with time, and the experimental group were lower than those in the control group, the differences were statistically significant (P<0.05). The serum calcium level of both groups increased with time, and the experimental group was higher than that in the control group, the difference was statistically significant (P<0.05). Serum FGF23 and blood uric acid were positively correlated with blood phosphorus, PTH, Scr and BUN (P<0.05), and negatively correlated with blood calcium (P<0.05).

Conclusion

Febuxostat combined with hemodialysis has a significant effect in patients with CKD, which can effectively improve serum FGF23 and bone metabolism, with good safety.

febuxostat  /  hemodialysis  /  chronic kidney disease  /  fibroblast growth factor 23  /  bone metabolism
张静, 杨晓宁, 李丽娜, 潘晓蓂. 非布司他联合血液透析对慢性肾脏病的疗效及对成纤维细胞生长因子23及骨代谢的影响. 世界临床药物, 2023 , 44 (6) : 632 -637 . DOI: 10.13683/j.wph.2023.06.020
Jing ZHANG, Xiaoning YANG, Lina LI, Xiaomi PAN. Effects of febuxostat combined with hemodialysis on chronic kidney disease and effect on fibroblast growth factor 23 and bone metabolism[J]. World Clinical Drug, 2023 , 44 (6) : 632 -637 . DOI: 10.13683/j.wph.2023.06.020
Year 2023 volume 44 Issue 6
11
0
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.06.020
  • Receive Date:2021-11-28
  • Online Date:2026-11-18
  • Published:2023-06-10
Article Data
Affiliations
History
  • Received:2021-11-28
  • Revised:2022-10-31
Affiliations
    1.Department of Internal Medicine, Qingdao Municipal Hospital Group, Qingdao Geriatric Hospital, Qingdao 266071, Shandong Province, China
    2.Blood Purification Center, Qingdao Municipal Hospital Group, Qingdao Geriatric Hospital, Qingdao 266071, Shandong Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.06.020
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT